EP0550465A4 - - Google Patents

Info

Publication number
EP0550465A4
EP0550465A4 EP19910915391 EP91915391A EP0550465A4 EP 0550465 A4 EP0550465 A4 EP 0550465A4 EP 19910915391 EP19910915391 EP 19910915391 EP 91915391 A EP91915391 A EP 91915391A EP 0550465 A4 EP0550465 A4 EP 0550465A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910915391
Other versions
EP0550465A1 (en
Inventor
Nina Martha Agabian
Ursula Edman
Isaura Meza Gomez-Palacio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of EP0550465A1 publication Critical patent/EP0550465A1/en
Publication of EP0550465A4 publication Critical patent/EP0550465A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP91915391A 1990-08-24 1991-08-21 Entamoeba histolytica immunodominant surface antigens Withdrawn EP0550465A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57291690A 1990-08-24 1990-08-24
US572916 1990-08-24

Publications (2)

Publication Number Publication Date
EP0550465A1 EP0550465A1 (en) 1993-07-14
EP0550465A4 true EP0550465A4 (zh) 1994-04-06

Family

ID=24289889

Family Applications (1)

Application Number Title Priority Date Filing Date
EP91915391A Withdrawn EP0550465A1 (en) 1990-08-24 1991-08-21 Entamoeba histolytica immunodominant surface antigens

Country Status (6)

Country Link
EP (1) EP0550465A1 (zh)
JP (1) JPH06500548A (zh)
AU (1) AU8445491A (zh)
BR (1) BR9106968A (zh)
MX (1) MX9100808A (zh)
WO (1) WO1992003457A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727223B2 (en) 2000-08-04 2004-04-27 Urex Biotech, Inc. Treatment of microbial infections with bacterial proteins and peptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002361A1 (en) * 1984-10-19 1986-04-24 Technology Licence Company Limited Monoclonal antibodies and their use
US5004608A (en) * 1988-01-13 1991-04-02 The University Of Virginia Alumni Patents Foundation Amebiasis vaccine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002361A1 (en) * 1984-10-19 1986-04-24 Technology Licence Company Limited Monoclonal antibodies and their use
US5004608A (en) * 1988-01-13 1991-04-02 The University Of Virginia Alumni Patents Foundation Amebiasis vaccine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BRUCE E. TORIAN ET AL.: "Use of monoclonal antibodies to identify, characterize , and purify a 96,000-Dalton surface antigen of pathogenic Entamoeba histolytica", THE JOURNAL OF INFECTIOUS DISEASES, vol. 156, no. 2, August 1987 (1987-08-01), pages 334 - 343 *
LIBRADO ORTIZ-ORTIZ ET AL.: "Entamoeba histolytica: specific antigen recognized by a monoclonal antibody", EXPERIMENTAL PARASITOLOGY, vol. 61, no. 3, June 1986 (1986-06-01), pages 390 - 397 *
See also references of WO9203457A1 *
URSULA EDMAN ET AL.: "Characterization of an immuno-dominant variable surface antigen from pathogenic and nonpathogenic Entamoeba histolytica", J. EXP. MED., vol. 172, no. 3, September 1990 (1990-09-01), pages 879 - 888, XP008007797, DOI: doi:10.1084/jem.172.3.879 *

Also Published As

Publication number Publication date
EP0550465A1 (en) 1993-07-14
JPH06500548A (ja) 1994-01-20
BR9106968A (pt) 1993-09-21
WO1992003457A1 (en) 1992-03-05
MX9100808A (es) 1992-11-01
AU8445491A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
FR2659604B1 (zh)
FR2671197B1 (zh)
DK0493553T3 (zh)
EP0460843A3 (zh)
FR2663985B1 (zh)
FR2670543B1 (zh)
FR2665536B1 (zh)
FR2662789B1 (zh)
FR2668928B1 (zh)
FR2660781B1 (zh)
FR2667981B1 (zh)
FR2659741B1 (zh)
FR2670660B1 (zh)
FR2668439B1 (zh)
FR2657124B1 (zh)
FR2668402B1 (zh)
FR2668576B1 (zh)
EP0505567A4 (zh)
FR2663443B1 (zh)
FR2668822B1 (zh)
FR2670336B1 (zh)
FR2669255B1 (zh)
FR2669884B1 (zh)
FR2670654B1 (zh)
FR2669053B1 (zh)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: C12N 15/30

A4 Supplementary search report drawn up and despatched

Effective date: 19940215

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19960102

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19960715